September 2017—Dx-Sys has developed an ultra-sensitive, lateral flow point-of-care diagnostic test for glial fibrillary acidic protein, a potential biomarker for traumatic brain injury.
Read More »September 2017—Dx-Sys has developed an ultra-sensitive, lateral flow point-of-care diagnostic test for glial fibrillary acidic protein, a potential biomarker for traumatic brain injury.
Read More »